-
1
-
-
0031941058
-
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
-
Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol. 1998;152(4):879-84.
-
(1998)
Am J Pathol.
, vol.152
, Issue.4
, pp. 879-884
-
-
Baba, M.1
Nakajo, S.2
Tu, P.H.3
Tomita, T.4
Nakaya, K.5
Lee, V.M.6
-
2
-
-
68149156531
-
Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: How neurons are lost in the Bermuda triangle
-
Malkus KA, Tsika E, Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener. 2009;4:24.
-
(2009)
Mol Neurodegener.
, vol.4
, pp. 24
-
-
Malkus, K.A.1
Tsika, E.2
Ischiropoulos, H.3
-
3
-
-
80054787664
-
What genetics tells us about the causes and mechanisms of Parkinson's disease
-
Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev. 2011;91(4):1161-218.
-
(2011)
Physiol Rev.
, vol.91
, Issue.4
, pp. 1161-1218
-
-
Corti, O.1
Lesage, S.2
Brice, A.3
-
4
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276(5321):2045-7.
-
(1997)
Science.
, vol.276
, Issue.5321
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
Ide, S.E.4
Dehejia, A.5
Dutra, A.6
-
5
-
-
0031990490
-
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
-
Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18(2):106-8.
-
(1998)
Nat Genet.
, vol.18
, Issue.2
, pp. 106-108
-
-
Kruger, R.1
Kuhn, W.2
Muller, T.3
Woitalla, D.4
Graeber, M.5
Kosel, S.6
-
6
-
-
10744230149
-
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
-
Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164-73.
-
(2004)
Ann Neurol.
, vol.55
, Issue.2
, pp. 164-173
-
-
Zarranz, J.J.1
Alegre, J.2
Gomez-Esteban, J.C.3
Lezcano, E.4
Ros, R.5
Ampuero, I.6
-
7
-
-
84879605541
-
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
-
Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord. 2013;28(6):811-3.
-
(2013)
Mov Disord.
, vol.28
, Issue.6
, pp. 811-813
-
-
Appel-Cresswell, S.1
Vilarino-Guell, C.2
Encarnacion, M.3
Sherman, H.4
Yu, I.5
Shah, B.6
-
8
-
-
84885461450
-
Alpha-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson's disease and multiple system atrophy?
-
Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, et al. alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol. 2013;125(5):753-69.
-
(2013)
Acta Neuropathol.
, vol.125
, Issue.5
, pp. 753-769
-
-
Kiely, A.P.1
Asi, Y.T.2
Kara, E.3
Limousin, P.4
Ling, H.5
Lewis, P.6
-
9
-
-
84876226920
-
A novel alpha-synuclein missense mutation in Parkinson disease
-
Proukakis C, Dudzik CG, Brier T, MacKay DS, Cooper JM, Millhauser GL, et al. A novel alpha-synuclein missense mutation in Parkinson disease. Neurology. 2012;80(11):1062-4.
-
(2012)
Neurology.
, vol.80
, Issue.11
, pp. 1062-1064
-
-
Proukakis, C.1
Dudzik, C.G.2
Brier, T.3
MacKay, D.S.4
Cooper, J.M.5
Millhauser, G.L.6
-
10
-
-
0242300619
-
Alpha-Synuclein locus triplication causes Parkinson's disease
-
Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302(5646):841.
-
(2003)
Science.
, vol.302
, Issue.5646
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
Singleton, A.4
Hague, S.5
Kachergus, J.6
-
11
-
-
4644290985
-
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
-
Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004;364(9440):1167-9.
-
(2004)
Lancet.
, vol.364
, Issue.9440
, pp. 1167-1169
-
-
Chartier-Harlin, M.C.1
Kachergus, J.2
Roumier, C.3
Mouroux, V.4
Douay, X.5
Lincoln, S.6
-
12
-
-
4644236043
-
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
-
Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 2004;364(9440):1169-71.
-
(2004)
Lancet.
, vol.364
, Issue.9440
, pp. 1169-1171
-
-
Ibanez, P.1
Bonnet, A.M.2
Debarges, B.3
Lohmann, E.4
Tison, F.5
Pollak, P.6
-
13
-
-
33645111633
-
Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease
-
Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet. 2006;15(7):1151-8.
-
(2006)
Hum Mol Genet.
, vol.15
, Issue.7
, pp. 1151-1158
-
-
Mizuta, I.1
Satake, W.2
Nakabayashi, Y.3
Ito, C.4
Suzuki, S.5
Momose, Y.6
-
14
-
-
84883557700
-
SNCA: Major genetic modifier of age at onset of Parkinson's disease
-
Brockmann K, Schulte C, Hauser AK, Lichtner P, Huber H, Maetzler W, et al. SNCA: major genetic modifier of age at onset of Parkinson's disease. Mov Disord. 2013;28(9):1217-21.
-
(2013)
Mov Disord.
, vol.28
, Issue.9
, pp. 1217-1221
-
-
Brockmann, K.1
Schulte, C.2
Hauser, A.K.3
Lichtner, P.4
Huber, H.5
Maetzler, W.6
-
15
-
-
77955366745
-
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: Implications for Parkinson's disease pathogenesis and therapies
-
Oueslati A, Fournier M, Lashuel HA. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res. 2010;183:115-45.
-
(2010)
Prog Brain Res.
, vol.183
, pp. 115-145
-
-
Oueslati, A.1
Fournier, M.2
Lashuel, H.A.3
-
16
-
-
68649095418
-
Molecular mechanisms of alpha-synuclein neurodegeneration
-
Waxman EA, Giasson BI. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta. 2009;1792(7):616-24.
-
(2009)
Biochim Biophys Acta.
, vol.1792
, Issue.7
, pp. 616-624
-
-
Waxman, E.A.1
Giasson, B.I.2
-
17
-
-
47249110199
-
The fold of alpha-synuclein fibrils
-
Vilar M, Chou HT, Luhrs T, Maji SK, Riek-Loher D, Verel R, et al. The fold of alpha-synuclein fibrils. Proc Natl Acad Sci U S A. 2008;105(25):8637-42.
-
(2008)
Proc Natl Acad Sci U S A.
, vol.105
, Issue.25
, pp. 8637-8642
-
-
Vilar, M.1
Chou, H.T.2
Luhrs, T.3
Maji, S.K.4
Riek-Loher, D.5
Verel, R.6
-
18
-
-
0037411282
-
4-Hydroxy-2-nonenal: A product and mediator of oxidative stress
-
Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003;42(4):318-43.
-
(2003)
Prog Lipid Res.
, vol.42
, Issue.4
, pp. 318-343
-
-
Uchida, K.1
-
19
-
-
84874372615
-
Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity
-
Xiang W, Schlachetzki JC, Helling S, Bussmann JC, Berlinghof M, Schaffer TE, et al. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol Cell Neurosci. 2013;54:71-83.
-
(2013)
Mol Cell Neurosci.
, vol.54
, pp. 71-83
-
-
Xiang, W.1
Schlachetzki, J.C.2
Helling, S.3
Bussmann, J.C.4
Berlinghof, M.5
Schaffer, T.E.6
-
20
-
-
79151470406
-
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties
-
Nasstrom T, Fagerqvist T, Barbu M, Karlsson M, Nikolajeff F, Kasrayan A, et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic Biol Med. 2010;50(3):428-37.
-
(2010)
Free Radic Biol Med.
, vol.50
, Issue.3
, pp. 428-437
-
-
Nasstrom, T.1
Fagerqvist, T.2
Barbu, M.3
Karlsson, M.4
Nikolajeff, F.5
Kasrayan, A.6
-
21
-
-
34247130917
-
Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation
-
Qin Z, Hu D, Han S, Reaney SH, Di Monte DA, Fink AL. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J Biol Chem. 2007;282(8):5862-70.
-
(2007)
J Biol Chem.
, vol.282
, Issue.8
, pp. 5862-5870
-
-
Qin, Z.1
Hu, D.2
Han, S.3
Reaney, S.H.4
Di Monte, D.A.5
Fink, A.L.6
-
22
-
-
84872971205
-
Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of alpha-synuclein
-
Bae EJ, Ho DH, Park E, Jung JW, Cho K, Hong JH, et al. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of alpha-synuclein. Antioxid Redox Signal. 2013;18(7):770-83.
-
(2013)
Antioxid Redox Signal.
, vol.18
, Issue.7
, pp. 770-783
-
-
Bae, E.J.1
Ho, D.H.2
Park, E.3
Jung, J.W.4
Cho, K.5
Hong, J.H.6
-
23
-
-
0025814980
-
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
-
Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81-128.
-
(1991)
Free Radic Biol Med.
, vol.11
, Issue.1
, pp. 81-128
-
-
Esterbauer, H.1
Schaur, R.J.2
Zollner, H.3
-
24
-
-
0029917194
-
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
-
Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A. 1996;93(7):2696-701.
-
(1996)
Proc Natl Acad Sci U S A.
, vol.93
, Issue.7
, pp. 2696-2701
-
-
Yoritaka, A.1
Hattori, N.2
Uchida, K.3
Tanaka, M.4
Stadtman, E.R.5
Mizuno, Y.6
-
25
-
-
24644514279
-
Evidence of oxidative stress in the neocortex in incidental Lewy body disease
-
Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R, Ferrer I. Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol. 2005;64(9):816-30.
-
(2005)
J Neuropathol Exp Neurol.
, vol.64
, Issue.9
, pp. 816-830
-
-
Dalfo, E.1
Portero-Otin, M.2
Ayala, V.3
Martinez, A.4
Pamplona, R.5
Ferrer, I.6
-
26
-
-
0037039837
-
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans
-
Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, et al. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett. 2002;319(1):25-8.
-
(2002)
Neurosci Lett.
, vol.319
, Issue.1
, pp. 25-28
-
-
Castellani, R.J.1
Perry, G.2
Siedlak, S.L.3
Nunomura, A.4
Shimohama, S.5
Zhang, J.6
-
27
-
-
84918816540
-
Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of alpha-synuclein
-
Rutherford NJ, Moore BD, Golde TE, Giasson BI. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of alpha-synuclein. J Neurochem. 2014;131(6):859-67.
-
(2014)
J Neurochem.
, vol.131
, Issue.6
, pp. 859-867
-
-
Rutherford, N.J.1
Moore, B.D.2
Golde, T.E.3
Giasson, B.I.4
-
28
-
-
84905852264
-
The H50Q mutation enhances alpha-synuclein aggregation, secretion and toxicity
-
Khalaf O, Fauvet B, Oueslati A, Dikiy I, Mahul-Mellier AL, Ruggeri FS, et al. The H50Q mutation enhances alpha-synuclein aggregation, secretion and toxicity. J Biol Chem. 2014;289(32):21856-76.
-
(2014)
J Biol Chem.
, vol.289
, Issue.32
, pp. 21856-21876
-
-
Khalaf, O.1
Fauvet, B.2
Oueslati, A.3
Dikiy, I.4
Mahul-Mellier, A.L.5
Ruggeri, F.S.6
-
29
-
-
84885439148
-
The Parkinson's disease-associated H50Q mutation accelerates alpha-Synuclein aggregation in vitro
-
Ghosh D, Mondal M, Mohite GM, Singh PK, Ranjan P, Anoop A, et al. The Parkinson's disease-associated H50Q mutation accelerates alpha-Synuclein aggregation in vitro. Biochemistry. 2013;52(40):6925-7.
-
(2013)
Biochemistry.
, vol.52
, Issue.40
, pp. 6925-6927
-
-
Ghosh, D.1
Mondal, M.2
Mohite, G.M.3
Singh, P.K.4
Ranjan, P.5
Anoop, A.6
-
30
-
-
84901717465
-
Residue histidine 50 plays a Key role in protecting alpha-synuclein from aggregation at physiological pH
-
Chi YC, Armstrong GS, Jones DN, Eisenmesser EZ, Liu CW. Residue histidine 50 plays a Key role in protecting alpha-synuclein from aggregation at physiological pH. J Biol Chem. 2014;289(22):15474-81.
-
(2014)
J Biol Chem.
, vol.289
, Issue.22
, pp. 15474-15481
-
-
Chi, Y.C.1
Armstrong, G.S.2
Jones, D.N.3
Eisenmesser, E.Z.4
Liu, C.W.5
-
31
-
-
79952742454
-
In vivo demonstration that alpha-synuclein oligomers are toxic
-
Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011;108(10):4194-9.
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, Issue.10
, pp. 4194-4199
-
-
Winner, B.1
Jappelli, R.2
Maji, S.K.3
Desplats, P.A.4
Boyer, L.5
Aigner, S.6
-
32
-
-
70350338222
-
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models
-
Karpinar DP, Balija MB, Kugler S, Opazo F, Rezaei-Ghaleh N, Wender N, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. Embo J. 2009;28(20):3256-68.
-
(2009)
Embo J.
, vol.28
, Issue.20
, pp. 3256-3268
-
-
Karpinar, D.P.1
Balija, M.B.2
Kugler, S.3
Opazo, F.4
Rezaei-Ghaleh, N.5
Wender, N.6
-
33
-
-
84922364789
-
Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment
-
Poehler AM, Xiang W, Spitzer P, May V, Meixner H, Rockenstein E, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10(12):2171-92.
-
(2014)
Autophagy.
, vol.10
, Issue.12
, pp. 2171-2192
-
-
Poehler, A.M.1
Xiang, W.2
Spitzer, P.3
May, V.4
Meixner, H.5
Rockenstein, E.6
-
34
-
-
84912083676
-
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation
-
Lazaro DF, Rodrigues EF, Langohr R, Shahpasandzadeh H, Ribeiro T, Guerreiro P, et al. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet. 2014;10(11):e1004741.
-
(2014)
PLoS Genet.
, vol.10
, Issue.11
-
-
Lazaro, D.F.1
Rodrigues, E.F.2
Langohr, R.3
Shahpasandzadeh, H.4
Ribeiro, T.5
Guerreiro, P.6
-
35
-
-
84862598619
-
Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway
-
Klucken J, Poehler AM, Ebrahimi-Fakhari D, Schneider J, Nuber S, Rockenstein E, et al. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy. 2012;8(5):754-66.
-
(2012)
Autophagy.
, vol.8
, Issue.5
, pp. 754-766
-
-
Klucken, J.1
Poehler, A.M.2
Ebrahimi-Fakhari, D.3
Schneider, J.4
Nuber, S.5
Rockenstein, E.6
-
36
-
-
0345826179
-
Conserved high affinity ligand binding and membrane association in the native and refolded extracellular domain of the human glycine receptor alpha1-subunit
-
Breitinger U, Breitinger HG, Bauer F, Fahmy K, Glockenhammer D, Becker CM. Conserved high affinity ligand binding and membrane association in the native and refolded extracellular domain of the human glycine receptor alpha1-subunit. J Biol Chem. 2004;279(3):1627-36.
-
(2004)
J Biol Chem.
, vol.279
, Issue.3
, pp. 1627-1636
-
-
Breitinger, U.1
Breitinger, H.G.2
Bauer, F.3
Fahmy, K.4
Glockenhammer, D.5
Becker, C.M.6
|